T. Clay
AuthID: R-00G-DWQ
1
TITLE: CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting Full Text
AUTHORS: Norell, H; Zhang, Y; McCracken, J; Martins Da Palma, T; Lesher, A; Liu, Y; Roszkowski, JJ; Temple, A; Callender, GG; Clay, T; Orentas, R; Guevara Patino, J; Nishimura, MI;
PUBLISHED: 2010, SOURCE: Cancer Immunology, Immunotherapy, VOLUME: 59, ISSUE: 6
AUTHORS: Norell, H; Zhang, Y; McCracken, J; Martins Da Palma, T; Lesher, A; Liu, Y; Roszkowski, JJ; Temple, A; Callender, GG; Clay, T; Orentas, R; Guevara Patino, J; Nishimura, MI;
PUBLISHED: 2010, SOURCE: Cancer Immunology, Immunotherapy, VOLUME: 59, ISSUE: 6
INDEXED IN: 
Scopus 
CrossRef
Scopus CrossRef